Ick-Hwan Son

Title: Ick-Hwan Son: Innovator in Pharmaceutical Chemistry

Introduction

Ick-Hwan Son is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific diseases.

Latest Patents

Ick-Hwan Son holds a patent for "Derivatives having 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same." This patent describes a compound that exhibits inhibitory activity against glucosylceramide synthase (GCS). The compound can be utilized in the prevention or treatment of various diseases associated with GCS, including Gaucher disease, Fabry disease, Tay-Sachs disease, and Parkinson's disease. He has 1 patent to his name.

Career Highlights

Throughout his career, Ick-Hwan Son has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Yuhan Corporation and The Green Cross Corporation. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Ick-Hwan Son has collaborated with several professionals in his field, including Dong-Hoon Kim and Jae-Eun Joo. These collaborations have likely enhanced his research and development efforts.

Conclusion

Ick-Hwan Son is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of serious diseases. His innovative approach and dedication to research continue to drive advancements in the field.